Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.

Saved in:
Bibliographic Details
Title: Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study.
Authors: Tesi B; Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden., Robelius A; Department of Medical Sciences, Section of Hematology, Uppsala University, Uppsala, Sweden., Baskin B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden., Lazarevic V; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Deneberg S; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Höglund M; Department of Medical Sciences, Section of Hematology, Uppsala University, Uppsala, Sweden., Fogelstrand L; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Laboratory Medicine, University of Gothenburg, Gothenburg, Sweden., Ungerstedt J; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Linköping University Hospital, Linköping, Sweden., Pandzic T; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.; Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Tobiasson M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Garelius HG; Department of Specialist Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden., Kuchinskaya E; Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Genetics, Linköping University, Linköping, Sweden.; Department of Clinical Experimental Medicine, Linköping University, Linköping, Sweden., Persson F; Department of Clinical Genetics and Genomics, Sahlgrenska University Hospital, Gothenburg, Sweden., Ågerstam H; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.; Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Lund, Sweden., Hallböök H; Department of Medical Sciences, Section of Hematology, Uppsala University, Uppsala, Sweden., Fioretos T; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.; Department of Clinical Genetics, Pathology and Molecular Diagnostics, Office for Medical Services, Lund, Sweden.; Clinical Genomics Lund, Science for Life Laboratory, Lund University, Lund, Sweden., Nordin J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Norberg A; Department of Medical Biosciences, Medical and Clinical Genetics, Umeå University, Umeå, Sweden., Thuresson AC; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden., Lehmann S; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Medical Sciences, Section of Hematology, Uppsala University, Uppsala, Sweden., Ladenvall C; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Barbany G; Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Vennström L; Department of Specialist Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden.; Institute of Medicine, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden., Ejerblad E; Department of Medical Sciences, Section of Hematology, Uppsala University, Uppsala, Sweden., Cavelier L; Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Cammenga J; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.; Division of Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden., Jädersten M; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Hellström-Lindberg E; Department of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden., Baliakas P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.; Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jul 15; Vol. 31 (14), pp. 3062-3071.
Publication Type: Journal Article; Multicenter Study; Validation Study
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-24-4251